Denali Therapeutics Stock (NASDAQ: DNLI) stock price, news, charts, stock research, profile.
Open | $30.94 |
Close | $30.91 |
Volume / Avg. | 2.00M / 1.10M |
Day Range | $30.65 - $31.24 |
52 Wk Range | 14.56 - 32.13 |
Market Cap | $4.43B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 77 |
Short Interest | 7.37% |
Days to Cover | 11.99 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Denali Therapeutics (NASDAQ:DNLI) through any online brokerage.
Other companies in Denali Therapeutics’s space includes: Immunovant (NASDAQ:IMVT), IDEAYA Biosciences (NASDAQ:IDYA), Ultragenyx Pharmaceutical (NASDAQ:RARE), Avidity Biosciences (NASDAQ:RNA) and MoonLake (NASDAQ:MLTX).
Denali Therapeutics has a consensus price target of $43.31.
The stock price for Denali Therapeutics (NASDAQ: DNLI) is $30.91 last updated September 20, 2024 at 4:02 PM EDT.
There are no upcoming dividends for Denali Therapeutics.
Denali Therapeutics’s Q3 earnings are confirmed for Tuesday, November 5, 2024.
There is no upcoming split for Denali Therapeutics.
Denali Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.